Identification Properties Safety Data Specifications & Other Information Links Identification CAS Number 161265-03-8 Name 3-(TRIFLUOROMETHYL)-5-P-TOLYL-1H-PYRAZOLE Synonyms 1H-Pyrazole, 3-(4-methylphenyl)-5-(trifluoromethyl)- [ACD/Index Name] 1H-Pyrazole, 5-(4-methylphenyl)-3-(trifluoromethyl)- 219986-64-8 [RN] 3-(4-Methylphenyl)-5-(trifluormethyl)-1H-pyrazol [German] [ACD/IUPAC Name] 3-(4-Methylphenyl)-5-(trifluoromethyl)-1H-pyrazole [ACD/IUPAC Name] 3-(4-Méthylphényl)-5-(trifluorométhyl)-1H-pyrazole [French] [ACD/IUPAC Name] 5-(4-Methylphenyl)-3-(trifluoromethyl)-1H-pyrazole MFCD03934062 [MDL number] [219986-64-8] [26974-15-2] 26974-15-2 [RN] ‘26974-15-2 3-(4-METHYLPHENYL)-5-(TRIFLUOROMETHYL)-2H-PYRAZOLE 3-(4-Methylphenyl)-5-(trifluoromethyl)pyrazole 3-(p-tolyl)-5-(trifluoromethyl)-1H-pyrazole 3-(TRIFLUOROMETHYL)-5-PARA-TOLYL-1H-PYRAZOLE 3-(Trifluoromethyl)-5-p-tolyl-1H- 3-(Trifluoromethyl)-5-p-tolyl-1H-pyrazole 3-Trifluoromethyl-5-(p-tolyl)-1H-pyrazole 403479-42-5 [RN] 5-(p-methylphenyl)-3-(trifluoromethyl)-1h-pyrazole 5-(p-Tolyl)-3-(trifluoromethyl)-1H-pyrazole…
[1,1′-Biphenyl]-2-carboxylic acid,4′-[(1,4′-dimethyl-2′-(1- chloropropyl)-[2,6′-bi-1H- benzimidazol]-1′-yl)methyl]- CAS WCNA-0132
WCNA-0132,[1,1′-Biphenyl]-2-carboxylic acid,4′-[(1,4′-dimethyl-2′-(1- chloropropyl)-[2,6′-bi-1H- benzimidazol]-1′-yl)methyl]-,Telmisartan
2,5′-Bi-1H-benzimidazole, 3′-(( 2′-carboxybiphenyl-4-yl)methyl)-3′-((2′-carboxybiphenyl-4-yl) methyl)-1,7′-dimethyl-2′-propyl- CAS WCNA-0134
WCNA-0134,2,5′-Bi-1H-benzimidazole, 3′-(( 2′-carboxybiphenyl-4-yl)methyl)-3′-((2′-carboxybiphenyl-4-yl) methyl)-1,7′-dimethyl-2′-propyl-,Telmisartan
2,5′-Bi-1H-benzimidazole, 2′- (1-chloropropyl)-1,7′-dimethyl- CAS WCNA-0126
WCNA-0126,2,5′-Bi-1H-benzimidazole, 2′- (1-chloropropyl)-1,7′-dimethyl-,Telmisartan
[1,1′-Biphenyl]-2-carboxylic acid, 4′-[(1,7′-dimethyl-2′- propyl[2,5′-bi-1H-benzimidazol]-3′-yl)methyl]-, methyl ester CAS WCNA-0128
WCNA-0128,[1,1′-Biphenyl]-2-carboxylic acid, 4′-[(1,7′-dimethyl-2′- propyl[2,5′-bi-1H-benzimidazol]-3′-yl)methyl]-, methyl ester,Telmisartan
[1,1′-Biphenyl]-2-nitrile,4′-[(1,7′-dimethyl-2′-propyl[2,5′-bi-1H- benzimidazol]-1′-yl)methyl]- CAS WCNA-0130
WCNA-0130,[1,1′-Biphenyl]-2-nitrile,4′-[(1,7′-dimethyl-2′-propyl[2,5′-bi-1H- benzimidazol]-1′-yl)methyl]-,Telmisartan
Narlaprevir impurities CAS WCNA-0115
WCNA-0115,Narlaprevir impurities,Narlaprevir
[1,1′-Biphenyl]-2-carboxylic acid,4′-[(1,4′-dimethyl-2′-(3- chloropropyl)-[2,6′-bi-1H- benzimidazol]-1′-yl)methyl] CAS WCNA-0131
WCNA-0131,[1,1′-Biphenyl]-2-carboxylic acid,4′-[(1,4′-dimethyl-2′-(3- chloropropyl)-[2,6′-bi-1H- benzimidazol]-1′-yl)methyl],Telmisartan
(6S)-6-N-[3-[(6S)-2-amino-4,5,6,7-tetrahydro-1,3-benzothiazol-6-yl]-1-ethyl-2-methylpropyl]-4,5,6,7-tetrahydro-1,3- benzothiazole-2,6-diamine CAS WCNA-0116
WCNA-0116,(6S)-6-N-[3-[(6S)-2-amino-4,5,6,7-tetrahydro-1,3-benzothiazol-6-yl]-1-ethyl-2-methylpropyl]-4,5,6,7-tetrahydro-1,3- benzothiazole-2,6-diamine,Pramipexole
Pentanamide, 2-methyl-3-oxo-,N-(2-amino-4,5,6,7-tetrahydro-6-benzothiazolyl)-,(6S)- CAS WCNA-0117
WCNA-0117,Pentanamide, 2-methyl-3-oxo-,N-(2-amino-4,5,6,7-tetrahydro-6-benzothiazolyl)-,(6S)-,Pramipexole